Bethanidine, nitroprusside and atrial natriuretic factor open a cGMP-sensitive K+ channel in aortic muscle.
Bkaily
G
G
Department of Physiology and Biophysics, Faculty of Medicine, University of Sherbrooke, Quebec, Canada.
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000502:physiology*; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D001627:Bethanidine / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology / Q000502:physiology*; D005292:Ferricyanides / Q000494:pharmacology*; D006146:Guanidines / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology*; D015221:Potassium Channels / Q000187:drug effects*; D011817:Rabbits
D005292:Ferricyanides; D006146:Guanidines; D015221:Potassium Channels; D009599:Nitroprusside; D015124:8-Bromo Cyclic Adenosine Monophosphate; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP; D001627:Bethanidine